performed previously [23 (link), 24 (link)]. The following antibodies and dyes were
used; Aqua LIVE/DEAD (Invitrogen), anti-CD3 BUV396 (UCHT1; BD Biosciences),
anti-CD19 BV510 (SJ25C1; BioLegend), anti-CD14 BV510 (M5E2; BioLegend), anti-CD4
BUV805 (SK3; BD Biosciences), anti-CD8 BV786 (RPA-T8; BD Biosciences), anti-CCR7
PE/Cy7 (G043H7; BioLegend), anti-CD45RA PE/TR (MEM-56; Invitrogen), anti-KLRG1
eFlour710/PerCP (13F12F2; eBioscience), anti-IFN-γ AF700 (B27;
BioLegend), anti-IL-2 APC/Cy7 (MQ1-17H12; BioLegend), anti-TNF-α Pacific
Blue (MAb11; BioLegend), anti-Perforin-1 PE (B-D48; Cell Sciences),
anti-Granzyme B PE/Cy5.5 (GB11; Invitrogen), anti-T-bet BV605 (4B10; BioLegend),
and anti-Eomesodermin (EOMES) eFlour660 (WD1928; eBioscience). Flow cytometric
analysis was performed on a LSRFortessa (BD Biosciences) and analyzed by Flowjo
v10.6.1. Statistics analysis was done by SPICE V6 [25 (link)] and GraphPad Prism 8.